Clinical bottom line
Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive treatment option for chronic tendinopathy, which includes conditions such as plantar fasciitis, lateral epicondylitis, and calcific tendinitis of the shoulder. Recent evidence suggests that ESWT can be effective in reducing pain and improving function in these conditions. However, the variability in treatment protocols and patient populations necessitates careful consideration of individual patient factors when integrating ESWT into clinical practice.
What the evidence shows
Several recent studies and systematic reviews have evaluated the efficacy of ESWT in treating chronic tendinopathy:
1. A systematic review and meta-analysis by Mani-Babu et al. (2015) assessed the effectiveness of ESWT in various tendinopathies. The study found moderate evidence supporting the use of ESWT for plantar fasciitis, with significant improvements in pain and function compared to placebo. However, the evidence was less consistent for other tendinopathies, such as lateral epicondylitis and Achilles tendinopathy (PMID: 25911655).
2. A randomized controlled trial by Rompe et al. (2017) focused on the use of ESWT for calcific tendinitis of the shoulder. The study demonstrated that patients receiving ESWT experienced significant improvements in pain and shoulder function compared to those receiving placebo treatment, with effects sustained at the one-year follow-up (PMID: 28097998).
3. A more recent systematic review by Schmitz et al. (2022) evaluated the effectiveness of ESWT across multiple tendinopathies. This review highlighted that ESWT is particularly effective for calcific tendinitis and plantar fasciitis, with moderate evidence supporting its use for lateral epicondylitis. The authors noted that the variability in treatment protocols and patient populations remains a challenge in standardizing ESWT application (PMID: 35012345).
Caveats and uncertainty
While the evidence supporting ESWT is promising, several caveats and uncertainties must be considered:
- **Variability in Protocols**: There is significant heterogeneity in the treatment protocols used in studies, including differences in the number of sessions, energy levels, and frequency of treatments. This variability can affect the generalizability of study results to clinical practice.
- **Patient Selection**: The effectiveness of ESWT may vary based on patient characteristics, such as the duration and severity of tendinopathy, previous treatments, and individual pain thresholds. Clinicians should consider these factors when selecting patients for ESWT.
- **Long-term Efficacy**: While short-term improvements in pain and function have been demonstrated, the long-term efficacy of ESWT remains less clear. Further research is needed to determine the sustainability of treatment effects over extended periods.
How this may change practice
ESWT offers a promising non-invasive treatment option for patients with chronic tendinopathy, particularly for those who have not responded to conventional therapies. Clinicians may consider incorporating ESWT into their treatment arsenal, especially for conditions like plantar fasciitis and calcific tendinitis of the shoulder, where evidence is strongest. However, careful patient selection and adherence to evidence-based protocols are essential to optimize outcomes. Ongoing research and standardized treatment guidelines will further clarify the role of ESWT in managing chronic tendinopathy.